These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32360116)

  • 41. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sudden cardiac death of rhythmic origin in athletes: literature review].
    Tlili R; Ben Ameur Y; Sdiri W; Ben Romdhane R; Bachraoui K; Boujnah MR
    Tunis Med; 2012 May; 90(5):345-50. PubMed ID: 22585639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
    Jordaens L; Tavernier R
    J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of sudden cardiac death in athletes, sportspersons and marathoners in India.
    Vora A; Burkule N; Contractor A; Bhargava K
    Indian Heart J; 2018; 70(1):137-145. PubMed ID: 29455769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
    Antoniades C; Tousoulis D; Stefanadis C
    Int J Cardiol; 2007 May; 118(2):170-2. PubMed ID: 16997401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is prevention of sudden death in young athletes feasible?
    Thiene G; Basso C; Corrado D
    Cardiologia; 1999 Jun; 44(6):497-505. PubMed ID: 10443050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Athletes at risk for sudden cardiac death.
    Subasic K
    J Sch Nurs; 2010 Feb; 26(1):18-25. PubMed ID: 19897607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
    Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Taking aspirin for prevention of "traveler's thrombosis"?].
    Stiefelhagen P
    Med Monatsschr Pharm; 2014 Jul; 37(7):259-60. PubMed ID: 25065162
    [No Abstract]   [Full Text] [Related]  

  • 50. Sudden cardiac death in young athletes: trying to find the needle in the haystack.
    Ng B; Maginot KR
    WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventing sudden cardiac death in athletes.
    Semsarian C; Ingles J
    BMJ; 2016 Apr; 353():i1270. PubMed ID: 27098379
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities.
    Link MS
    Br J Sports Med; 2009 Sep; 43(9):685-9. PubMed ID: 19734503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sudden cardiac death in athletes: is it always not preventable?].
    Vernuccio F; Grutta G; Fazio G
    Recenti Prog Med; 2014 Nov; 105(11):410-4. PubMed ID: 25424234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial.
    Myles PS; Smith JA; Kasza J; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; McGuinness S; Chan MTV; Wallace S; Forbes A;
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):633-640. PubMed ID: 30401528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice.
    Eikelboom JW; Hankey GJ
    Am J Cardiovasc Drugs; 2004; 4(1):57-67. PubMed ID: 14967066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
    La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sudden death predictors: an inflammatory association.
    Spooner PM; Zipes DP
    Circulation; 2002 Jun; 105(22):2574-6. PubMed ID: 12045156
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapy with aspirin: a new look at the old problem].
    Katkova OV; Laguta PS; Panchenko EP
    Angiol Sosud Khir; 2007; 13(2):9-14. PubMed ID: 18004254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining aspirin with antithrombotic agents.
    Sung JJ
    BMJ; 2006 Oct; 333(7571):712-3. PubMed ID: 17023437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.